View Author
patient treatment cancer study cisplatin chemotherapy response month survival angiosarcoma group oncology m-cavi phase trial toxicity disease cycle analysis marker grade hd-ct result therapy death oncol hd-vip paclitaxel oncology information downloaded gemcitabine m-cavi arm scalp society difference etoposide american society erasmus universiteit rotterdam bajorin gc arm response rate bajorin risk groups high-dose sarcoma table firmed randomized factor decline progression signi erasmu reason grade 3 tissue ifosfamide erasmus mc marker decline urothelial /carboplatin firmed uncon firmed medische bibliotheek volume 22 | number high-dose chemotherapy downloaded methotrexate bladder cisplatin-based chemotherapy university bajorin risk factors bladder cancer information 0.0 metastase 5 | tumor santi hd-ct arm carboplatin cisplatin therapy
